Nearly one-third of American consumers report experiencing a steep increase over the last year in prices paid for drugs they routinely take, which is having a spillover effect on all phases of their lives.
Nearly one-third of American consumers report experiencing a steep increase over the last year in prices paid for drugs they routinely take, which is having a spillover effect on all phases of their lives, from retirement planning to how much they can spend on groceries, according to a report from Consumer Reports.
The report is based on a survey of a nationally representative sample of consumers as well as a survey asking physicians how they address the issue of medication affordability. Survey respondents reported that had to make tradeoffs between paying for the medications they needed and necessities such as groceries and health care. Health insurance plans with very high deductibles forced many to shop around for lower prices and not use their insurance, said Lisa Gill, deputy editor of Consumer Reports Best Buy Drugs.
“Consumers aren’t used to questioning prices for pharmaceutical drugs—nor are they used to shopping around and haggling—but they could save themselves a lot of money if they do,” Gill said in a statement.
The new report found that consumers who experienced higher drug prices in the last 12 months were more likely to economize with their health in potentially dangerous ways. The following statistics compare all survey respondents taking a prescription drug with those who experienced a price increase: not complying with prescription medications to save money (33% vs 47%), putting off doctors’ visits because of cost (18% vs 28%), declining a medical test or procedure because of cost (14% vs 23%), and not filling a prescription because of cost (17% vs 30%), taking an expired medication (12% vs 19%), or not taking a scheduled dosage or prescribed medication to save money (10% vs 17%).
The survey also found that in the past year, consumers who took prescription medications took the following steps in order to pay for their prescription medications: spent less on entertainment and dining out (24% of all respondents vs 38% of those experiencing a price increase), got an insurance policy that covered medications (20% vs 24%), spent less on groceries (17% vs 31%), used credit cards more often (15% vs 25%), spend less on family (14% vs 25%), postponed paying other bills (11% vs 19%), postponed retirement to maintain health insurance coverage (6% vs 10%), and took a second job(4% vs 7%).
Consumer Reports identified 5 key reasons for the rise in drug prices profiled in their report:
Finally, the survey found that despite the burdens created by higher drug prices, only one-fourth of consumers surveyed said they discussed drug costs with their practitioners. Of those who did have such a discussion, 64% said they initiated it--a finding corroborated by the results of Consumer Report’s survey of internal medicine physicians. The physicians said in a typical week they discuss drug costs with only 2.6 of 10 patients, even though 80% of the physicians said they were concerned about their patients’ ability to pay for their treatments.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More